Gazyva (obinutuzumab) 1,000 mg Gazyva (obinutuzumab) is used for approved indications including chronic lymphocytic leukemia and follicular lymphoma. Medicine delivery from Europe within 4-5 days. Order at +380996042415 via Viber or WhatsApp.
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications
Chronic lymphocytic leukemia (CLL)
Gazyva® in combination with chlorambucil is indicated for the treatment of adult patients with chronic lymphocytic leukemia who have not received prior treatment and have co-morbidities that preclude full-dose fludarabine therapy.
Follicular lymphoma (FL)
Gazyva® in combination with chemotherapy followed by maintenance therapy with the drug Gazyva® when a response is achieved is indicated for the treatment of patients with previously untreated advanced follicular lymphoma.
Gazyva® in combination with bendamustine followed by maintenance therapy with the drug Gazyva® is indicated for the treatment of patients with follicular lymphoma who did not respond to treatment with rituximab or combination therapy that included rituximab, or whose disease progressed during or within 6 months of treatment with rituximab or after combination therapy that included rituximab.
- Trade name:Gazyva
- Chemical name:Obinutuzumab
- Dosage:1000 mg
- Quantity:1
- Dosage form:Solution
